These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 8266913

  • 1. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
    Wada H, Kaneko T, Ohiwa M, Tanigawa M, Hayashi T, Tamaki S, Minami N, Deguchi K, Suzuki K, Nakano T.
    Am J Hematol; 1993 Oct; 44(2):101-5. PubMed ID: 8266913
    [Abstract] [Full Text] [Related]

  • 2. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
    Wada H, Minamikawa K, Wakita Y, Nakase T, Kaneko T, Ohiwa M, Tamaki S, Deguchi K, Shirakawa S, Hayashi T.
    Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
    [Abstract] [Full Text] [Related]

  • 3. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
    Watanabe R, Wada H, Miura Y, Murata Y, Watanabe Y, Sakakura M, Okugawa Y, Nakasaki T, Mori Y, Nishikawa M, Gabazza EC, Shiku H, Nobori T.
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
    [Abstract] [Full Text] [Related]

  • 4. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
    Wada H, Mori Y, Shimura M, Hiyoyama K, Ioka M, Nakasaki T, Nishikawa M, Nakano M, Kumeda K, Kaneko T, Nakamura S, Shiku H.
    Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
    [Abstract] [Full Text] [Related]

  • 5. Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia.
    Wada H, Mori Y, Kaneko T, Wakita Y, Nakase T, Minamikawa K, Ohiwa M, Tamaki S, Tanigawa M, Kageyama S.
    Am J Hematol; 1993 Oct; 44(2):112-6. PubMed ID: 8266915
    [Abstract] [Full Text] [Related]

  • 6. Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis.
    López-Aguirre Y, Páramo JA.
    Thromb Res; 1999 Apr 15; 94(2):95-101. PubMed ID: 10230894
    [Abstract] [Full Text] [Related]

  • 7. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR, Rosenfeld CS, Andrews DF, Nemunaitis J, Raymond JM, Shadduck RK, Kramer RE, Gryn JF, Rintels PB, Besa EC, George JN.
    Am J Hematol; 1996 Dec 15; 53(4):213-20. PubMed ID: 8948657
    [Abstract] [Full Text] [Related]

  • 8. Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Mori Y, Wada H, Okugawa Y, Tamaki S, Nakasaki T, Watanabe R, Gabazza EC, Nishikawa M, Minami N, Shiku H.
    Clin Appl Thromb Hemost; 2001 Jan 15; 7(1):5-9. PubMed ID: 11190905
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
    Zhou K, Zhang J, Zheng ZR, Zhou YZ, Zhou X, Wang LD, Suo B, Jiang XF, Liu PJ, Wang DH.
    Clin Appl Thromb Hemost; 2020 Jan 15; 26():1076029620971041. PubMed ID: 33141604
    [Abstract] [Full Text] [Related]

  • 10. Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice.
    Tersteeg C, Joly BS, Gils A, Lijnen R, Deckmyn H, Declerck PJ, Plaimauer B, Coppo P, Veyradier A, Maas C, De Meyer SF, Vanhoorelbeke K.
    J Thromb Haemost; 2017 Dec 15; 15(12):2432-2442. PubMed ID: 28981198
    [Abstract] [Full Text] [Related]

  • 11. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
    Kario K, Matsuo T.
    Atherosclerosis; 1993 Nov 15; 103(2):131-8. PubMed ID: 8292090
    [Abstract] [Full Text] [Related]

  • 12. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan 15; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 13. Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF.
    Bellucci S, Ignatova E, Jaillet N, Boffa MC.
    Thromb Haemost; 1993 Nov 15; 70(5):736-42. PubMed ID: 8128427
    [Abstract] [Full Text] [Related]

  • 14. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
    Koike K, Fujimaki M.
    Nihon Rinsho; 1993 Jan 15; 51(1):37-42. PubMed ID: 8433526
    [Abstract] [Full Text] [Related]

  • 15. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M, Mari D, Meroni PL, Gronda E, Vicari F, Frigerio M, Coppola R, Bottasso B, Borghi MO, Gregorini L.
    Br J Haematol; 2004 Jul 15; 126(1):85-92. PubMed ID: 15198737
    [Abstract] [Full Text] [Related]

  • 16. Fibrinogenolysis in thrombotic thrombocytopenic purpura.
    Kakishita E, Koyama T, Higuchi M, Kunitomi O, Oura Y, Nagai K.
    Am J Hematol; 1989 Sep 15; 32(1):14-9. PubMed ID: 2502913
    [Abstract] [Full Text] [Related]

  • 17. Thrombin generation in patients with thrombotic thrombocytopenic purpura.
    Takahashi H, Tatewaki W, Wada K, Shibata A.
    Am J Hematol; 1989 Dec 15; 32(4):255-7. PubMed ID: 2479264
    [Abstract] [Full Text] [Related]

  • 18. Circulating thrombomodulin in thrombotic thrombocytopenic purpura.
    Takahashi H, Hanano M, Wada K, Tatewaki W, Niwano H, Tsubouchi J, Nakano M, Nakamura T, Shibata A.
    Am J Hematol; 1991 Nov 15; 38(3):174-7. PubMed ID: 1659186
    [Abstract] [Full Text] [Related]

  • 19. Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns.
    Aoki K, Aikawa N, Sekine K, Yamazaki M, Mimura T, Urano T, Takada A.
    Burns; 2001 Sep 15; 27(6):569-75. PubMed ID: 11525850
    [Abstract] [Full Text] [Related]

  • 20. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy.
    Fujiwara Y, Tagami S, Kawakami Y.
    J Atheroscler Thromb; 1998 Sep 15; 5(1):21-8. PubMed ID: 10077454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.